Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesPotential Combination Chemotherapy Approaches for Advanced Adult-Type Soft-Tissue Sarcoma
American Journal of Clinical Dermatology, 11/19/08
Kopp HG et al. - Novel compounds such as bevacizumab, multi-tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, imatinib, and the thrombospondin agonist ABT 510 represent attractive partners for the above-mentioned cytostatic agents, or may even be effective single agents in the clinically advanced setting.
| Previous Article | Next Article |
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dapsone 5 Gel: A Review of its Efficacy and Safety in the Treatment of Acne Vulgaris
American Journal of Clinical Dermatology, 06/09/09
Guidelines for the diagnosis and treatment of dermatitis herpetiformis
Journal of the European Academy of Dermatology and Venereology, 06/01/09
5% 5-Fluorouracil Cream for Treatment of Verruca Vulgaris in Children
Pediatric Dermatology, 06/26/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitamin D and Melanoma
Annals of Epidemiology , 06/15/09
Pediatric Melanoma: A Review
Cancer Control, 06/29/09
Treatments for psoriasis and the risk of malignancy
Journal of the American Academy of Dermatology, 06/05/09
Article Search
Sponsor